Celon Pharma S.A. (WSE:CLN)
Poland · Delayed Price · Currency is PLN 21.70
+0.05 (0.23%)
Mar 5, 2026, 3:45 PM CET
Celon Pharma Market Cap
Celon Pharma has a market cap or net worth of 1.17 billion as of March 5, 2026. Its market cap has decreased by -9.60% in one year.
Market Cap
1.17B
Enterprise Value
1.16B
Revenue
225.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.70
Market Cap Chart
Since December 1, 2016, Celon Pharma's market cap has increased from 1.00B to 1.17B, an increase of 16.30%. That is a compound annual growth rate of 1.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 1.17B | 6.39% |
| Dec 30, 2025 | 1.10B | -23.06% |
| Dec 30, 2024 | 1.42B | 80.47% |
| Dec 29, 2023 | 789.33M | 10.32% |
| Dec 30, 2022 | 715.51M | -57.68% |
| Dec 30, 2021 | 1.69B | -7.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.07B |
| NEUCA | 3.33B |
| Synektik Spólka Akcyjna | 2.45B |
| Voxel | 1.35B |
| Selvita | 758.08M |
| Centrum Medyczne ENEL-MED | 593.89M |
| Ryvu Therapeutics | 578.00M |
| Scope Fluidics | 456.86M |